85.83
price up icon0.34%   0.375
 
loading
Biontech Se Adr stock is traded at $85.83, with a volume of 278.02K. It is up +0.34% in the last 24 hours and up +1.31% over the past month. BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
See More
Previous Close:
$85.46
Open:
$86.72
24h Volume:
278.02K
Market Cap:
$20.50B
Revenue:
$2.95B
Net Income/Loss:
$118.10M
P/E Ratio:
7.4391
EPS:
11.5384
Net Cash Flow:
$5.34B
1W Performance:
+1.78%
1M Performance:
+1.31%
6M Performance:
-14.09%
1Y Performance:
-21.03%
1D Range:
Value
$84.42
$86.80
52W Range:
Value
$78.02
$125.83

Biontech Se Adr Stock (BNTX) Company Profile

Name
Name
Biontech Se Adr
Name
Phone
-
Name
Address
-
Name
Employee
6,133
Name
Twitter
@BioNTech_Group
Name
Next Earnings Date
2024-08-05
Name
Latest SEC Filings
Name
BNTX's Discussions on Twitter

Biontech Se Adr Stock (BNTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-24 Initiated Oppenheimer Perform
Dec-01-23 Downgrade JP Morgan Neutral → Underweight
Oct-16-23 Downgrade HSBC Securities Buy → Hold
Jul-14-23 Initiated HSBC Securities Buy
May-17-23 Upgrade Redburn Neutral → Buy
Dec-15-22 Upgrade BofA Securities Neutral → Buy
Aug-17-22 Initiated Cowen Market Perform
Jul-13-22 Upgrade SVB Leerink Mkt Perform → Outperform
Jul-06-22 Resumed Canaccord Genuity Buy
Feb-01-22 Upgrade Redburn Sell → Neutral
Dec-16-21 Initiated Morgan Stanley Equal-Weight
Nov-10-21 Upgrade H.C. Wainwright Neutral → Buy
Oct-22-21 Initiated Deutsche Bank Hold
Oct-07-21 Initiated Jefferies Hold
Aug-11-21 Upgrade Bryan Garnier Neutral → Buy
Jul-19-21 Resumed Wolfe Research Outperform
Jun-16-21 Downgrade Redburn Neutral → Sell
May-18-21 Initiated Goldman Neutral
May-11-21 Downgrade Bryan Garnier Buy → Neutral
Dec-01-20 Downgrade BofA Securities Buy → Neutral
Aug-03-20 Resumed Berenberg Buy
Jul-21-20 Upgrade BofA Securities Neutral → Buy
Jun-30-20 Downgrade H.C. Wainwright Buy → Neutral
May-19-20 Upgrade H.C. Wainwright Neutral → Buy
Apr-28-20 Downgrade BofA/Merrill Buy → Neutral
Mar-18-20 Downgrade JP Morgan Overweight → Neutral
Mar-09-20 Initiated H.C. Wainwright Neutral
Jan-24-20 Downgrade SVB Leerink Outperform → Mkt Perform
Jan-22-20 Downgrade UBS Buy → Neutral
Nov-05-19 Initiated Wolfe Research Outperform
Nov-04-19 Initiated Berenberg Buy
Nov-04-19 Initiated BofA/Merrill Buy
Nov-04-19 Initiated Canaccord Genuity Buy
Nov-04-19 Initiated JP Morgan Overweight
Nov-04-19 Initiated SVB Leerink Outperform
Nov-04-19 Initiated UBS Buy
View All

Biontech Se Adr Stock (BNTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$27.79
price up icon 0.18%
$160.82
price up icon 3.91%
$85.52
price up icon 1.86%
$460.67
price down icon 2.23%
$236.66
price down icon 0.46%
Cap:     |  Volume (24h):